Name | Description | Official Website | Industry | Launch Date | Product Parent Company | ||
|---|---|---|---|---|---|---|---|
Prescription medicine used to treat people with perinatal/infantile- and juvenile-onset hypophosphatasia (HPP). | |||||||
SOLIRIS®(eculizumab) injection, for intravenous use. | |||||||
Prescription medication used to treat people with a diagnosis of LAL-D. | |||||||
Long-acting medication. | |||||||
FDA-approved prescription medicine. |